Background: Accumulated evidence suggests that spinal cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) may be implicated in the development of opioid-induced hyperalgesia.
Editor's key points
Repeated opioid administration can induce hyperalgesia and can result in chronic postsurgical pain. The roles of cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) and its receptor, EP-1R, in the development of acute fentanyl-induced hyperalgesia was investigated in a rat model. Repeated fentanyl administration dose-dependently causes mechanical hyperalgesia and worsens surgeryinduced postoperative hyperalgesia. Hyperalgesia was accompanied by increases in spinal COX-2 and PGE2 and was prevented by inhibitors of COX-2 or blockade of EP-1R. COX-2 and PGE2 seem to be involved in fentanylinduced hyperalgesia and possibly chronic postsurgical pain.
Opioid-induced hyperalgesia (OIH) is defined as the paradoxical effect that opioids decrease pain thresholds and increase atypical pain unrelated to the original, preexisting pain. 1 OIH often occurs upon repeated injections with opioid drugs such as morphine, remifentanil, or fentanyl in animal models. 2e5 Recently, in some clinical settings acute exposure to opioids, such as perioperative remifentanil or fentanyl, was implicated in induction of hyperalgesia and partly contributed to chronic postsurgical pain, a significant problem with a high incidence (10e50%). 6e8 Recent evidence indicated that perioperative OIH was mainly associated with the use of high doses of remifentanil. 5, 9 Remifentanil is a short-acting opioid and is widely used intraoperatively. However, the role of long-acting opioids such as fentanyl and sufentanil in perioperative OIH, is unclear, although a few studies suggest that fentanyl, especially at high doses, induced hyperalgesia and increased postoperative pain in animal models and human trials. 3, 9, 10 Preclinical studies suggest that neuroinflammation, especially in the spinal cord, as indicated by the upregulation of proinflammatory factors such as prostaglandin E2 (PGE2) 11e13 and cyclooxygenase-2 (COX-2), 14, 15 contributes to the development of OIH. However, current data cannot explain the relationship between acute OIH and changes in proinflammatory factors such as COX-2 and PGE2 in the spinal cord. COX-2, one of two COX isoforms, is particularly relevant for inflammation-induced PGE2 formation. PGE2 is a key mediator of exaggerated pain sensation in acute and chronic pain conditions through the activation of four PGE2 receptor subtypes (EP1e4). 16 Notably, the EP1 receptor (EP-1R) played a key role in facilitating the generation of nociception induced by injury and inflammation and contributing predominantly to PGE2-associated hyperalgesia. 16e18 The aim of this study was to determine the role of the spinal COX-2/PGE2/EP-1R pathway in the acute fentanyl-induced hyperalgesia in rats.
Methods

Animals
The experimental protocol was approved by Institutional Laboratory Animal Care and Use Committee of Sun Yat-sen University and experiments are reported in accordance with relevant aspects of the ARRIVE guidelines. Adult male SpragueeDawley rats (Sun Yat-Sen University LAC, Guangzhou, China), weighing 200e250 g at the start of the experiments, were used. The rats were housed under conditions of controlled temperature (20e24 C) and humidity (40e70%) and were habituated to the environment for at least 3 days before the experiments. Two or three rats were kept in each cage, under a 12 h light and dark cycle, with free access to food and water. Drug administration and behaviour tests were performed during the daytime.
Behaviour tests
Mechanical nociceptive thresholds of the tail were assessed by the tail-pressure test with the use of a ZH-YLS-3E Analgesy Meter (Zhenghua, Anhui, China) as described previously. 19, 20 Briefly, the distal part of the tail was supported by a plinth while pressure, linearly increasing at a rate of 10 g s
À1
, was applied with a cone-shaped pusher. The proximal 2 cm of the tail was marked, and with each successive trial on the same day, a new pressure point was positioned 0.25 cm proximal to the site of the previous pressure point. The end-point was defined as the first motor response of struggling against the pressure. The baseline mechanical nociceptive threshold was between 300 and 320 g. A cut-off point, in the absence of response, was set at 600 g, to avoid tissue damage. Before the experiment, rats received a 3-day training session.
The thermal nociceptive test was carried out as described previously. 21 A plantar test apparatus (IITC, Chicago, IL, USA) was used to evaluate thermal nociception. Briefly, the rat was placed in a plexiglass box on a glass plate. A beam of light passed through the glass to the middle plantar aspect of the hind paw near the toes ipsilateral to the surgical site. The intensity of the beam was set at 30 W and the diameter was 5 mm. The paw withdrawal latency was recorded as the length of time between the onset of the light beam and paw withdrawal. The 20-s cut-off time was used to avoid tissue damage.
Surgery
Rats were anaesthetized with 1.5e2% isoflurane (Jiupai Company, Hebei, China) delivered via a nose cone. 22 Adequate anaesthesia was ascertained by the lack of pedal withdrawal response to a nociceptive stimulus. After the plantar aspect of the left hind paw was sterilized with a 10% povidoneeiodine solution, a 1-cm longitudinal incision was made through the skin, fascia, and muscle. The incision started 0.5 cm from the proximal edge of heel and extended to the toes, as described previously. 23 A 4-0 silk was used to suture the skin. All incisions were made after the second injection of fentanyl or normal saline. The rats in the sham surgery groups received anaesthesia but without surgical incision.
Drugs
Fentanyl citrate (Humanwell, Yichang, China) was dissolved in normal saline for subcutaneous (s.c.) administration at the volume of 0. 
PGE2 measurements
After the rats received 1% pentobarbital intraperitoneally (i.p.) at 40 mg kg À1 (Xiya Reagent, Chengdu, China), they were killed by cervical dislocation. The lumbar enlargement of the spinal cord (L4eL6) was immediately exposed by laminectomy, removed, and divided into left and right halves. The samples were snap-frozen in liquid nitrogen for 20 s and then stored at À80 C until the time of assay. Half of the collected samples were prepared for enzyme immunoassay as described previously 24 and detailed in Supplementary File 1.
COX-2 and EP-1R mRNA measurements
The remaining half of the collected samples were used for reverse transcriptionepolymerase chain reaction (RT-PCR). Briefly, the sample was homogenized in RNAiso Plus (Takara Bio Inc., Otsu, Japan) and RNA was extracted from homogenate supernatants according to the manufacturer's instructions. After RNA concentrations were determined spectrophotometrically, 1 mg of total RNA was reverse transcribed using oligo dT primer and PrimeScript RT Enzyme Mix I (Takara Bio Inc., Otsu, Japan). PCR was performed using SYBR Premix Ex Taq™. The primers used for PCR and the detail PCR amplification are described in Supplementary File 2. The relative expression of COX-2 mRNA and EP-1R mRNA were analysed using the 2 eDDCT method as previously described.
25,26
Medication and measurement protocols Injections were repeated at 15-min intervals, resulting in total doses of 0, 80, 160, 240, and 320 mg kg À1 fentanyl respectively.
The tail pressure test was carried out 1 day prior to injection and 1, 2, 3, and 4 h, and 1, 2, 3, 4, and 5 days after injection. In addition, on day 1 after fentanyl injection, seven rats from each group after the tail pressure test were randomly selected for the harvesting of the L4eL6 spinal cord for COX-2 and EP-1R mRNA and PGE2 assay.
To assess the time course of fentanyl, groups of rats (n¼7) received (s.c.) four doses of 60 mg kg À1 fentanyl. On day 1 prior to injection and 4 h, and 1, 2, 3, and 5 days after injection, seven rats from each group after the tail pressure test were randomly selected for the harvesting of the L4-L6 spinal cord for COX-2 and EP-1R mRNA and PGE2 assay.
To assess the effects of parecoxib on SC51089, four groups of rats (n¼13) received either normal saline (i.p.) followed by . The dosages of all drugs used were based on previous studies 27, 28 and our pilot study. The tail pressure test was carried out 1 day before injection and 1, 2, 3, and 4 h, and 1, 2, 3, 4, and 5 days after injection. Additionally, 1 day after injection, seven rats in each group after the tail pressure test were randomly selected for the harvesting of the L4eL6 spinal cord for COX-2 and EP-1R mRNA and PGE2 assay.
To exclude the possibility that tail stimulation during tail pressure test affected hyperalgesia, a group of rats received i.p.
saline then four injections of 60 mg kg À1 fentanyl but the tail pressure test was not carried out at 0e4 hours.
To assess the effect of fentanyl on surgery induced hyperalgesia, four groups of rats (n¼10) received either four s.c. injections of normal saline plus sham surgery, or four injections of saline with surgical incision, or four doses of 60 mg kg À1 fentanyl plus sham surgery or four doses of fentanyl 60 mg kg À1 plus incision. Surgery was carried out just before the second injection of fentanyl or normal saline. Behavioural tests to assess mechanical and thermal nociceptive thresholds were performed 1 day before injection and 1, 2, 3, and 4 h, and 1, 2, 3, 4, 5, 6, and 7 days after injection.
Statistical analysis
Data are expressed as mean and standard deviation. Nociceptive thresholds or latencies were quantified as either direct measurement data or the area under the responseetime curve (AUC). The AUC was calculated according to the following formula based on the trapezoid rule: AUC ¼ 1 h or 1 day Â (the sum of data measured at set time points)/2. Data were analysed using analysis of variance, followed by the Dunnett test and P<0.05 was considered statistically significant.
Results
As shown in Fig. 1A , increased mechanical nociceptive thresholds in the tail pressure test were seen at 1, 2, and 3 h after repeated fentanyl injections at all doses. In contrast, mechanical hyperalgesia was observed on days 1e4 after fentanyl injections shown by significant decreases in the nociceptive thresholds, which gradually returned to basal levels by day 5. The duration of mechanical hyperalgesia was dose dependent (Fig. 1A) .
There was no difference between the different doses of repeated fentanyl injections on the AUCs of mechanical nociceptive thresholds at 1e4 h but the AUCs were greater than from animals receiving saline (Fig. 1B) . AUCs from mechanical thresholds at days 1e5 were lower in rats receiving fentanyl and were dose related (Fig 1B) . COX-2 mRNA and PGE2 protein expression increased with fentanyl dose (Fig. 1C and  D) . The levels of COX-2 mRNA and PGE2 protein on day 1 after fentanyl injections dose-dependently increased as the dose of fentanyl increased (Fig. 1C and D) . In contrast, EP-1R mRNA expression were not affected by the dosage of fentanyl (data not shown). COX-2 mRNA and PGE2 protein expression were higher at days 1 and 2, or at 4 h, day 1, and 2 after fentanyl injections, respectively, and peaked at day 1 after fentanyl injections, compared to baseline (Fig. 2) but EP-1R mRNA expression was only increased on day 5 after fentanyl injections, compared to baseline (Fig. 3) .
Pretreatment with the selective COX-2 inhibitor, parecoxib, did not affect the antinociceptive effect of fentanyl at 1e4 h but significantly attenuated the mechanical hyperalgesia seen later (Fig. 4A) . The duration of mechanical hyperalgesia in rats given parecoxib and four doses of 60 mg kg À1 fentanyl lasted 1 day, which was less than for those receiving fentanyl without parecoxib (Fig. 4A) . Pretreatment with the EP-1R antagonist, SC51089, also did not affect antinociception induced by fentanyl, but completely abolished the mechanical hyperalgesia evoked by fentanyl injections (Fig. 4A) . As expected, the AUCs of thresholds from testing at 1e4 h in rats receiving fentanyl were greater than animals receiving saline, regardless of the inhibitors. Additionally, the AUCs from tests at 1e5 days from rats given fentanyl with parecoxib or SC51089 were higher than that of rats receiving fentanyl with saline (Fig. 4B) .
Compared with rats receiving only saline, the levels of COX-2 mRNA and PGE2 protein were increased on day 1 after fentanyl injections regardless of whether parecoxib was given ( Fig. 4C and D) . The rise in PGE2 but not COX-2 expression was slightly lower in rats given fentanyl plus parecoxib (Fig. 4D) . Parecoxib had no effect on EP-1R mRNA expression (data not shown).
Incision produced mechanical hyperalgesia, as demonstrated by marked decreases in the mechanical thresholds at 3 and 4 h in rats given saline only (Fig. 5A) . The duration of hyperalgesia in the animals receiving fentanyl and undergoing incision was longer (5 days) than those receiving fentanyl with sham surgery (3 days) or saline with incision (2 days; Fig. 5A) . A significant analgesic effect was observed at 1e3 h after fentanyl injections in rats given fentanyl with either sham surgery or incision (Fig. 5A) . AUCs from tests at 1e4 h were higher in rats given fentanyl than those given saline alone and were lower in incision compared to sham surgery in the animals given saline (Fig. 5B) . As expected, the day 1e7 AUCs of mechanical hypersensitivity tests from rats given saline with sham surgery were higher than all other groups (Fig. 5B) , whilst AUCs from those receiving fentanyl plus incision were lowest (Fig. 5B) . Similar effects of fentanyl on incision-induced thermal hyperalgesia were observed (Supplemental Material 3; Fig. 5C and D) . 
Discussion
In the present study, we found that repeated injections of fentanyl at different doses produced a dose-dependent mechanical hyperalgesia. The expressions of COX-2 mRNA and PGE2 protein were also dose-dependently increased in the spinal cord after fentanyl. Furthermore, pretreatment with the selective COX-2 inhibitor, parecoxib, and the PGE2 downstream subtype receptor EP-1 antagonist, SC51089, attenuated fentanyl-induced mechanical hyperalgesia. Also, pretreatment with parecoxib partly blocked the increased level of spinal PGE2 but not COX-2 mRNA by fentanyl injections. Finally, injections of fentanyl augmented incision-evoked mechanical and thermal hyperalgesia. Taken together, our findings suggest that spinal cord COX-2 and PGE2 play a role in fentanyl-induced pain hypersensitivity under incisional pain conditions.
We showed that acute fentanyl injections increased the levels of spinal COX-2 mRNA and PGE2 protein in rats. These increases were accompanied mechanical hyperalgesia induced by fentanyl, both peaking at day 1 after fentanyl injections. The changes in behavioural responses and spinal COX-2 and PGE2 levels suggest a role for spinal COX-2 and PGE2 in fentanyl-induced hyperalgesia. Our observation that the COX-2 inhibitor, parecoxib, significantly attenuated fentanyl-induced hyperalgesia further supports this conclusion. These preclinical results are consistent with human clinical trials where parecoxib had a significant inhibitory effect on remifentanil-induced hyperalgesia. 29, 30 However, the increases in COX-2 and PGE2 lasted for only 2 days, whereas mechanical hyperalgesia persisted for at least 3 days. It is likely that other mechanisms also contribute to fentanylinduced behaviours. For example, the activation of spinal Nmethyl-D-aspartic acid (NMDA) receptors may contribute to mechanical hyperalgesia. 3, 9 Interestingly, a recent human study 31 revealed that acute remifentanil infusion induced hyperalgesia but did not increase the level of cerebrospinal fluid (CSF) PGE2 and that intrathecal ketorolac, a COX inhibitor, failed to reduce remifentanil post-infusion hyperalgesia or concentrations of CSF PGE2. The reason for the difference in our findings and the previous study are unknown. It may reflect different experimental conditions, for example, dosage (high vs low), the types of opioids (fentanyl vs remifentanil), the method of administration (interrupted injection vs continuous infusion), the type of tissue collected for PGE2 assay (spinal cord vs CSF), or the behavioural test used (pawwithdrawal and tail-pressure test vs capsaicin-evoked hypersensitivity). The difference in the opioid dosage is the most likely reason for the inconsistent observations. Based on the dose translation from rat to human, 32 the doses of fentanyl used in our study (80e320 mg kg À1 in 1 h) is equivalent to a dose in humans of (13e51.9 mg kg À1 h À1 ) 32 and is higher than clinical doses used (2e10 mg kg À1 h À1 ). 33 However, the dose of remifentanil (1 ng ml À1 ) used in the study of Eisenach and colleagues was lower than that commonly used clinically (2e4 ng ml À1 ). 33 Moreover, the increases in spinal COX-2 mRNA and PGE2 induced by fentanyl in our study are dosedependent. Thus, it is very likely that the low doses of remifentanil used in may not be enough to induce detectable PGE2 in the spinal cord and CSF. It is possible that intrathecal ketorolac did not produce significant effects on remifentanilinduced hyperalgesia or CSF PGE2 because of the lack of an increase in CSF PGE2. 31, 34 Reportedly, COX-2 expression is increased in the injured nerves and ipsilateral dorsal spinal cord following peripheral nerve injury.
35 PGE2 was also found to increase in spinal cord and/or in CSF in acute and chronic peripheral inflammation, 36, 37 in a postoperative pain rat model, 12 in neuropathic animal models, 38, 39 and in patients after surgery of total hip replacement. 40 Mice deficient in PGE2 production, displayed impaired dorsal horn activation of microglia and mechanical allodynia after peripheral nerve injury. 41 These studies indicated PGE2 is a key feature of hyperalgesic priming and might be sufficient to induce and maintain central sensitization in inflammatory-pain, postoperative-pain, and neuropathic-pain states. Previous studies demonstrated that withdrawal from chronic morphine, but not chronic morphine treatment itself, resulted in increased spinal PGE2. 13 However, it is unclear whether acute (e.g. intraoperative administration) opioid administration directly induces increase of COX-2 and PGE2 in the spinal cord. Our study provides direct evidence that acute fentanyl injections increased the levels of COX-2 mRNA and PGE2 in the spinal cord. Our study also demonstrated that fentanyl injections produced enhanced effects on incisioninduced mechanical and thermal hyperalgesia. Recently, Araldi and colleagues reported that repeated injections of the selective m-opioid receptor agonist (over 3 h) induced mechanical hyperalgesia and marked prolongation of PGE2 hyperalgesia for 38 days, indicating the effect of acute opioid administration on long-lasting hyperalgesia. 42 These results strongly suggest a direct contribution of spinal PGE2 induced by acute opioid administration to central sensitization, which is a potential adverse effect on the development of chronic postsurgical pain. In this study, we found that the COX-2 inhibitor parecoxib, partly, and its downstream EP-1 receptor antagonist SC51089, completely inhibited mechanical hyperalgesia induced by fentanyl. This partial inhibition by parecoxib is unlikely to be due to insufficient doses. 28 In addition, higher doses of parecoxib (20 mg kg À1 ) in pilot experiments (data not shown) had similar effects. Biosynthesis of PGE2 comprises several steps: arachidonic acid is converted to prostaglandin H2 (PGH2) by constitutively expressed COX-1 or the inducible COX-2, and then PGH2 is converted to PGE2 by PGE synthase. Systemic and local indomethacin (a nonselective non-steroidal anti-inflammatory drug) and selective EP-1 antagonists have better effects on attenuating pain behaviours and hyperalgesia than selective COX-2 inhibitors in neuropathic pain animal models. 41, 43 Kunori and colleagues 41 found that spinal PGE2, but not COX-2, is involved in the maintenance of neuropathic pain because microsomalprostaglandinesynthase-1 (mPGES-1) can utilize PGH2 as a substrate, unlike in inflammatory pain. In this study, we found that intraoperative fentanyl induced an earlier increase of PGE2 than COX-2 ( Fig. 2 ) and that pretreatment with the selective COX-2 inhibitor resulted in a partial blockage of the increased level of spinal PGE2 by fentanyl injections. As the development of hyperalgesia may share some common mechanism with neuropathic pain, 11, 44 we speculate that the contribution of spinal PGE2 may include both COX-1 and COX-2 (spinal COX-2 only partially affects the synthesis of PGE2). This is supported by the fact that the EP-1 antagonist completely inhibited, but the selective COX-2 inhibitor partially inhibited, fentanyl-induced hyperalgesia. The contribution of PGE2 to neuropathic pain may be mediated through its downstream receptors. PGE2 receptors, particularly the EP-1 receptor, were upregulated in the injured nerves or surrounding tissues 2e4 weeks after partial sciatic nerve ligation in rats and in human injured brachial plexus nerves, painful neuromas, and avulsion injured dorsal root ganglion. 35 It is generally considered that the EP-1 receptor,
and not EP2e4 receptors, contribute mainly to PGE2-associated hyperalgesia although the detailed role of EP-1 receptor is unclear. 16, 18 We found that expression of EP-1R mRNA in the spinal cord was not related to fentanyl dosage and that it did not change on days 1e4, and increased on day 5 after fentanyl injections, at which time the mechanical and thermal hyperalgesia disappeared. The reason for the delayed increase of EP-1R is unknown and needs to be further investigated. We acknowledge limitations in the present study, including that: 1) we did not assess dose related thermal hyperalgesia by fentanyl injection, although we demonstrated that fentanyl at 60 mg kg À1 evoked marked thermal hyperalgesia; 2) no change of COX-2 and PGE2 in the spinal cord were seen after surgical incision and fentanyl injections; and 3) we did not examine the effect of COX-1 inhibition or the roles of other PGE2 receptor subtypes, such as EP2, EP3, and EP4, on hyperalgesia. Future studies will address these issues.
In conclusion, we have shown that acute repeated injections of fentanyl induced dose-dependent mechanical hyperalgesia, with increased levels of spinal COX-2 mRNA and PGE2. Inhibition of COX-2 and its downstream subtype receptor EP-1 significantly attenuated the mechanical hyperalgesia induced by fentanyl. Repeated injections of fentanyl aggravated mechanical and thermal hyperalgesia induced by surgical incision. These results indicate an important role of spinal COX-2 and PGE2 in the development of fentanylinduced hyperalgesia and that they may be involved in the transition from acute postoperative pain to chronic postsurgical pain.
